Browse by Author "Firvida Perez, Jose Luis"

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis

2012- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results

2013- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results

2013- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Barón Duarte, Francisco Javier

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

2014- Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Alonso-Jaudenes Curbera, Guillermo [et al.]

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer:

2019- Campelo, R. G.; Vázquez Rivera, Francisca; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vazquez, S.; [et al.]

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; León Mateos, Luis Ángel; [et al.]

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

2013- Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; López Vázquez, María Dolores [et al.]

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group

2012- Firvida Perez, Jose Luis; Castro Gómez, José Enrique; Vázquez Estévez, Sergio; Barón Duarte, Francisco Javier; Taboada Valladares, Maria Begoña [et al.]

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

2013- Pena Álvarez, Carolina; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña [et al.]

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

2019- ARIAS RON, DAVID; LABANDEIRA GUERRA, CARMEN MARIA; Areses Manrique, María Carmen; SAMPEDRO DOMARCO, PAULA; Abdulkader Nallib, Ihab; [et al.]

EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER

2013- Firvida Perez, Jose Luis; Areses Manrique, María Carmen

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

2011- Afonso Afonso, Francisco Javier; Firvida Perez, Jose Luis; Varela Ferreiro, Silvia; Campos Balea, Begoña; Barón Duarte, Francisco Javier [et al.]

Eficacia, toxicidad y adherencia terapéutica de gefitinib en el tratamiento del cáncer de pulmón no microcítico

2012- Firvida Perez, Jose Luis; Pereira Vázquez, María; Fernández Montes, Ana; Castro Gómez, José Enrique; Nuñez Viejo, Miguel Angel; [et al.]

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

2019- AGRASO BUSTO, SARA; VARELA POSE, VANESA; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Santome, L.; [et al.]

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

2012- Afonso Afonso, Francisco Javier; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Fernández Montes, Ana; [et al.]

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

2011- Firvida Perez, Jose Luis; Fernández Montes, Ana; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)

2011- Fernández Calvo, Ovidio; García Mata, Jesús; Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]

RUNA digital repository

Browse by Author "Firvida Perez, Jose Luis"

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis ﻿

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results ﻿

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results ﻿

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. ﻿

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer: ﻿

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples ﻿

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study ﻿

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group ﻿

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group ﻿

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group ﻿

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group ﻿

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report ﻿

EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER ﻿

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study ﻿

Eficacia, toxicidad y adherencia terapéutica de gefitinib en el tratamiento del cáncer de pulmón no microcítico ﻿

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation ﻿

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study ﻿

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP) ﻿

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09) ﻿

A phase II study of cisplatin (CDDP) and oral vinorelbine (NVBO) concomitantly with radiotherapy (RT) in locally advanced (LA) non-small cell lung cancer (NSCLC) treatment: Interim analysis

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Eficacy and safety results

A phase II study of cisplatin and oral vinorelbine concomitantly with radiotherapy in locally advanced non-small-cell lung cancer treatment: Primary objective and safety results

A Phase II Trial of Erlotinib as Maintenance Treatment After Concurrent Chemo-radiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) - a Galician Lung Cancer Group (GGCP) Study

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer:

Analysis of the expression of Wnt signaling ligands in metastatic renal cell carcinomas tissue samples

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

Biweekly docetaxel-cisplatin in chemonaive patients with advanced epidermoid carcinoma of the lung - A phase II study of galician lung cancer group

Concurrent chemoradiation (CCHRT) for stage III non-small cell lung cancer (NSCLC): A phase II study from the galician lung cancer group

Concurrent chemoradiation (cchrt) with bi-weekly docetaxel and cisplatin and thoracic radiotherapy for stage iii non-small cell lung cancer (nsclc): a phase ii study from the galician lung cancer group

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER

Efficacy and safety of pemetrexed-cisplatin for advanced non-squamous non-small cell lung cancer - A galician lung cancer group study

Eficacia, toxicidad y adherencia terapéutica de gefitinib en el tratamiento del cáncer de pulmón no microcítico

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

Erlotinib as frontline treatment for elderly patients (P) with advanced non-squamous non-small cell lung cancer (NSNSCLC): GGCP044/09 study

Erlotinib as frontline treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC) and non-squamous histology - Results of a galician lung cancer group (GGCP044/09 study) grupo galego de cancro de pulmon (GGCP)

Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)